Inventor
WANG ZHAOLIN
US32 patents
⚠️ This page may combine multiple inventors who share the name “WANG ZHAOLIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RA PHARMACEUTICALS INC
16 patentsUS10588936B2Mar 17, 2020
Modulators of complement activity
RA PHARMACEUTICALS INC13 citations93
US10328115B2Jun 25, 2019
Modulators of complement activity
RA PHARMACEUTICALS INC15 citations93
US10106579B2Oct 23, 2018
Modulation of complement activity
RA PHARMACEUTICALS INC19 citations93
US10435438B2Oct 8, 2019
Modulation of complement activity
RA PHARMACEUTICALS INC12 citations92
US10208089B2Feb 19, 2019
Modulation of complement activity
RA PHARMACEUTICALS INC12 citations92
US9937222B2Apr 10, 2018
Modulators of complement activity
RA PHARMACEUTICALS INC14 citations92
US11014965B2May 25, 2021
Modulation of complement activity
RA PHARMACEUTICALS INC3 citations83
US10918691B2Feb 16, 2021
Modulators of complement activity
RA PHARMACEUTICALS INC2 citations72
US10272132B2Apr 30, 2019
Peptide and peptidomimetic inhibitors
RA PHARMACEUTICALS INC1 citations72
US12239684B2Mar 4, 2025
Modulators of complement activity
RA PHARMACEUTICALS INC0 citations62
US11965040B2Apr 23, 2024
Modulation of complement activity
RA PHARMACEUTICALS INC0 citations62
US11707503B2Jul 25, 2023
Modulators of complement activity
RA PHARMACEUTICALS INC0 citations62
US11535650B1Dec 27, 2022
Modulation of complement activity
RA PHARMACEUTICALS INC0 citations62
US9644004B2May 9, 2017
Peptide and peptidomimetic inhibitors
RA PHARMACEUTICALS INC1 citations61
US9238676B2Jan 19, 2016
Peptide and peptidomimetic inhibitors
RA PHARMACEUTICALS INC2 citations61
US9999650B2Jun 19, 2018
Peptide and peptidomimetic inhibitors
RA PHARMACEUTICALS INC0 citations51